Literature DB >> 22162467

Muscle-bone characteristics in children with Prader-Willi syndrome.

Thomas Edouard1, Cheri Deal, Guy Van Vliet, Natacha Gaulin, Alain Moreau, Frank Rauch, Nathalie Alos.   

Abstract

BACKGROUND: A decrease in muscle mass, low motor performance, and normal lumbar spine bone mineral density (BMD) have been reported in children with Prader-Willi syndrome (PWS). However, these data are limited by the fact that PWS children (who have short stature) were compared to age-matched healthy or obese individuals of normal height.
OBJECTIVE: The goal of the present study was to compare bone and muscle characteristics in PWS children to sex- and age- or height-matched healthy subjects.
MATERIALS AND METHODS: The study population included 17 PWS children (ages 6.2 to 17.5 yr; nine girls) who were not treated with GH. The axial skeleton was analyzed at the lumbar spine using dual-energy x-ray absorptiometry, and the appendicular skeleton (radius and tibia) was evaluated using peripheral quantitative computed tomography. Muscle parameters (mass, size, and functional parameters) were measured by dual-energy x-ray absorptiometry, peripheral quantitative computed tomography, and jumping mechanography, respectively.
RESULTS: Compared to height-matched controls, PWS patients had normal axial and appendicular BMD, as well as normal muscle size. Compared to age- or height-matched controls of normal weight, PWS patients had lower maximal muscle force and power relative to body mass during jumping. PWS patients had similar absolute maximal muscle force but lower absolute maximal power compared to age- or height-matched controls. Relationships between bone mass and muscle size and force were similar in PWS patients and in healthy subjects.
CONCLUSION: Relative to their height, PWS patients not treated with GH had normal axial and appendicular BMD, muscle size, and muscle-bone relationships.

Entities:  

Mesh:

Year:  2011        PMID: 22162467     DOI: 10.1210/jc.2011-2406

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  11 in total

Review 1.  Review of Prader-Willi syndrome: the endocrine approach.

Authors:  Ryan Heksch; Manmohan Kamboj; Kathryn Anglin; Kathryn Obrynba
Journal:  Transl Pediatr       Date:  2017-10

2.  Growth hormone in health and disease: Prader-Willi syndrome--GH therapy and bone.

Authors:  Graziano Grugni
Journal:  Nat Rev Endocrinol       Date:  2013-04-09       Impact factor: 43.330

Review 3.  Cellular and disease functions of the Prader-Willi Syndrome gene MAGEL2.

Authors:  Klementina Fon Tacer; Patrick Ryan Potts
Journal:  Biochem J       Date:  2017-06-16       Impact factor: 3.857

4.  Reference data for jumping mechanography in Canadian children, adolescents and young adults.

Authors:  L Gabel; H M Macdonald; L Nettlefold; D Race; H A McKay
Journal:  J Musculoskelet Neuronal Interact       Date:  2016-12-14       Impact factor: 2.041

Review 5.  Growth hormone therapy for Prader-willi syndrome: challenges and solutions.

Authors:  Graziano Grugni; Alessandro Sartorio; Antonino Crinò
Journal:  Ther Clin Risk Manag       Date:  2016-06-02       Impact factor: 2.423

6.  Prader-Willi Critical Region, a Non-Translated, Imprinted Central Regulator of Bone Mass: Possible Role in Skeletal Abnormalities in Prader-Willi Syndrome.

Authors:  Ee-Cheng Khor; Bruce Fanshawe; Yue Qi; Sergei Zolotukhin; Rishikesh N Kulkarni; Ronaldo F Enriquez; Louise Purtell; Nicola J Lee; Natalie K Wee; Peter I Croucher; Lesley Campbell; Herbert Herzog; Paul A Baldock
Journal:  PLoS One       Date:  2016-01-29       Impact factor: 3.240

7.  Experience with jumping mechanography in children with cerebral palsy.

Authors:  I Duran; K Martakis; C Stark; E Alberg; C Bossier; O Semler; E Schoenau
Journal:  J Musculoskelet Neuronal Interact       Date:  2017-09-01       Impact factor: 2.041

Review 8.  Peripheral quantitative computed tomography (pQCT) for the assessment of bone strength in most of bone affecting conditions in developmental age: a review.

Authors:  Stefano Stagi; Loredana Cavalli; Tiziana Cavalli; Maurizio de Martino; Maria Luisa Brandi
Journal:  Ital J Pediatr       Date:  2016-09-26       Impact factor: 2.638

Review 9.  The RDoC approach for translational psychiatry: Could a genetic disorder with psychiatric symptoms help fill the matrix? the example of Prader-Willi syndrome.

Authors:  Juliette Salles; Emmanuelle Lacassagne; Grégoire Benvegnu; Sophie Çabal Berthoumieu; Nicolas Franchitto; Maithé Tauber
Journal:  Transl Psychiatry       Date:  2020-08-08       Impact factor: 6.222

Review 10.  Irisin and Secondary Osteoporosis in Humans.

Authors:  Roberta Zerlotin; Angela Oranger; Patrizia Pignataro; Manuela Dicarlo; Filippo Maselli; Giorgio Mori; Silvia Concetta Colucci; Maria Grano; Graziana Colaianni
Journal:  Int J Mol Sci       Date:  2022-01-08       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.